Literature DB >> 17709413

Differential contribution of bacterial N-formyl-methionyl-leucyl- phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia.

Jean-François Gauthier1, Andrée Fortin, Yves Bergeron, Marie-Christine Dumas, Marie-Eve Champagne, Michel G Bergeron.   

Abstract

Despite the development of new potent antibiotics, Streptococcus pneumoniae remains the leading cause of death from bacterial pneumonia. Polymorphonuclear neutrophil (PMN) recruitment into the lungs is a primordial step towards host survival. Bacterium-derived N-formyl peptides (N-formyl-methionyl-leucyl-phenylalanine [fMLP]) and host-derived chemokines (KC and macrophage inflammatory protein 2 [MIP-2]) are likely candidates among chemoattractants to coordinate PMN infiltration into alveolar spaces. To investigate the contribution of each in the context of pneumococcal pneumonia, CD1, BALB/c, CBA/ca, C57BL/6, and formyl peptide receptor (FPR)-knockout C57BL/6 mice were infected with 10(6) or 10(7) CFU of penicillin/erythromycin-susceptible or -resistant serotype 3 or 14 S. pneumoniae strains. Antagonists to the FPR, such as cyclosporine H (CsH) and chenodeoxycholic acid, or neutralizing antibodies to KC and MIP-2 were injected either 1 h before or 30 min after infection, and then bronchoalveolar lavage fluids were obtained for quantification of bacteria, leukocytes, and chemokines. CsH was effective over a short period after infection with a high inoculum, while anti-CXC chemokine antibodies were effective after challenge with a low inoculum. CsH prevented PMN infiltration in CD1 mice infected with either serotype 3 or 14, whereas antichemokine antibodies showed better efficacy against the serotype 3 strain. When different mouse strains were challenged with serotype 3 bacteria, CsH prevented PMN migration in the CD1 mice only, whereas the antibodies were effective against CD1 and C57BL/6 mice. Our results suggest that fMLP and chemokines play important roles in pneumococcal pneumonia and that these roles vary according to bacterial and host genetic backgrounds, implying redundancy among chemoattractant molecules.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709413      PMCID: PMC2168265          DOI: 10.1128/IAI.02008-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  The chemoattractant receptors FPR and C5aR: same functions--different fates.

Authors:  François Boulay; Marie-Josèphe Rabiet
Journal:  Traffic       Date:  2005-02       Impact factor: 6.215

2.  Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia.

Authors:  Matthew R Jones; Benjamin T Simms; Michal M Lupa; Mariya S Kogan; Joseph P Mizgerd
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 3.  Leukotriene B4.

Authors:  S W Crooks; R A Stockley
Journal:  Int J Biochem Cell Biol       Date:  1998-02       Impact factor: 5.085

4.  Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.

Authors:  Y Bergeron; N Ouellet; A M Deslauriers; M Simard; M Olivier; M G Bergeron
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 5.  Role of C5a in inflammatory responses.

Authors:  Ren-Feng Guo; Peter A Ward
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.

Authors:  Gwenny M Fuhler; Gerlinde J Knol; A Lyndsay Drayer; Edo Vellenga
Journal:  J Leukoc Biol       Date:  2004-11-23       Impact factor: 4.962

Review 7.  Neutrophils in the innate immune response.

Authors:  Scott D Kobayashi; Jovanka M Voyich; Christopher Burlak; Frank R DeLeo
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2005 Nov-Dec       Impact factor: 4.291

8.  Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

9.  The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia.

Authors:  R Jounblat; H Clark; P Eggleton; S Hawgood; P W Andrew; A Kadioglu
Journal:  Respir Res       Date:  2005-10-28

10.  N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR.

Authors:  J K Hartt; G Barish; P M Murphy; J L Gao
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

View more
  20 in total

1.  Comparison of pulmonary inflammatory and antioxidant responses to intranasal live and heat-killed Streptococcus pneumoniae in mice.

Authors:  Miroslava Dominis-Kramarić; Martina Bosnar; Zeljko Kelnerić; Ines Glojnarić; Snježana Cužić; Michael J Parnham; Vesna Eraković Haber
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

2.  Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.

Authors:  Yoshitaka Sogawa; Takao Ohyama; Hiroaki Maeda; Kazuki Hirahara
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

3.  Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.

Authors:  Sandra Oldekamp; Sebastian Pscheidl; Eugenia Kress; Oliver Soehnlein; Sandra Jansen; Thomas Pufe; Ji Ming Wang; Simone C Tauber; Lars-Ove Brandenburg
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

4.  Ectopic Expression of Human Thymosin β4 Confers Resistance to Legionella pneumophila during Pulmonary and Systemic Infection in Mice.

Authors:  Bonggoo Park; Min Hwa Shin; Jiyoung Kim; Gayoung Park; Yun-Kyoung Ryu; Jae-Wook Lee; Tae Jin Kim; Eun-Yi Moon; Kyung-Mi Lee
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

5.  Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.

Authors:  Keer Sun; Yan Gan; Dennis W Metzger
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

6.  Intratracheal instillation of neutrophils rescues bacterial overgrowth initiated by trauma damage-associated molecular patterns.

Authors:  Kiyoshi Itagaki; Ingred Riça; Jing Zhang; Dave Gallo; Melissa DePrato; Leo E Otterbein; Carl J Hauser
Journal:  J Trauma Acute Care Surg       Date:  2017-05       Impact factor: 3.313

7.  Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia.

Authors:  Irena Kukavica-Ibrulj; Marie-Eve Hamelin; Gregory A Prince; Constance Gagnon; Yves Bergeron; Michel G Bergeron; Guy Boivin
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

Review 8.  The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

Authors:  David A Dorward; Christopher D Lucas; Gavin B Chapman; Christopher Haslett; Kevin Dhaliwal; Adriano G Rossi
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

9.  The α-tocopherol form of vitamin E reverses age-associated susceptibility to streptococcus pneumoniae lung infection by modulating pulmonary neutrophil recruitment.

Authors:  Elsa N Bou Ghanem; Stacie Clark; Xiaogang Du; Dayong Wu; Andrew Camilli; John M Leong; Simin N Meydani
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

10.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.